Literature DB >> 10404326

Factors associated with trimethoprim-resistant bacteria isolated from urine samples.

D T Steinke1, R A Seaton, G Phillips, T M MacDonald, P G Davey.   

Abstract

Urine samples with trimethoprim-resistant or trimethoprim-sensitive Gram-negative bacteria and samples with no bacterial growth (NG) were identified. Age-sex matched community controls were generated with each trimethoprim-resistant case. These four groups were evaluated for exposure. Prior trimethoprim use was significantly more common in the trimethoprim-resistant group when compared with the trimethoprim-sensitive or the NG group. Prior hospitalization was significantly less common in the trimethoprim-resistant than the trimethoprim-sensitive group, but not with the NG group. Prior oestrogen exposure was associated with trimethoprim resistance. There were no associations found for diabetes or prior corticosteroid exposure. Community controls were found to be inappropriate controls for the study of trimethoprim-resistant bacteria in urine samples.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10404326     DOI: 10.1093/jac/43.6.841

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

Review 1.  Best practice in primary care pathology: review 2.

Authors:  W S Smellie; J O Forth; C A M McNulty; L Hirschowitz; D Lilic; R Gosling; D Bareford; E Logan; K G Kerr; G P Spickett; J Hoffman; A Galloway; C A Bloxham
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

2.  Containing antibiotic resistance: decreased antibiotic-resistant coliform urinary tract infections with reduction in antibiotic prescribing by general practices.

Authors:  Chris C Butler; Frank Dunstan; Margaret Heginbothom; Brendan Mason; Zoë Roberts; Sharon Hillier; Robin Howe; Stephen Palmer; Anthony Howard
Journal:  Br J Gen Pract       Date:  2007-10       Impact factor: 5.386

3.  Trimethoprim prescription and subsequent resistance in childhood urinary infection: multilevel modelling analysis.

Authors:  Mary A Duffy; Virginia Hernandez-Santiago; Gillian Orange; Peter G Davey; Bruce Guthrie
Journal:  Br J Gen Pract       Date:  2013-04       Impact factor: 5.386

4.  Antibiotic-resistant infections in primary care are symptomatic for longer and increase workload: outcomes for patients with E. coli UTIs.

Authors:  Christopher C Butler; Sharon Hillier; Zoë Roberts; Frank Dunstan; Anthony Howard; Stephen Palmer
Journal:  Br J Gen Pract       Date:  2006-09       Impact factor: 5.386

5.  Increased treatment failure after 3-days' courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database.

Authors:  Wim G Goettsch; Rob Janknegt; Ron M C Herings
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

6.  Association between antimicrobial consumption and resistance in Escherichia coli.

Authors:  Miika Bergman; Solja T Nyberg; Pentti Huovinen; Pirkko Paakkari; Antti J Hakanen
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

7.  Impact of Changing Patterns of Antimicrobial Resistance in Uropathogens: Emerging Treatment and Strategies.

Authors:  Patricia D. Brown
Journal:  Curr Infect Dis Rep       Date:  2003-12       Impact factor: 3.725

8.  Prevalence and risk factor analysis of resistant Escherichia coli urinary tract infections in the emergency department.

Authors:  Abby M Bailey; Kyle A Weant; Stephanie N Baker
Journal:  Pharm Pract (Granada)       Date:  2013-06-30

Review 9.  Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies.

Authors:  Muhammad Sajid Hamid Akash; Kanwal Rehman; Fareeha Fiayyaz; Shakila Sabir; Mohsin Khurshid
Journal:  Arch Microbiol       Date:  2020-02-03       Impact factor: 2.667

10.  The influence of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in elderly adult patients with urinary tract infection.

Authors:  Mario Bonadio; Silvia Costarelli; Giovanna Morelli; Tiziana Tartaglia
Journal:  BMC Infect Dis       Date:  2006-03-17       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.